After Jerusalem signed binding term sheet for purchase of drug, CEO of Arcturus Therapeutics says Phase 3 study needs to be held in location with substantial number of cases
TV reports country to buy four million units of drug made by Arcturus Therapeutics and Singapore's Duke-NUS medical school, recently granted permission to begin clinical trails
Jerusalem's Gamida Cell says 'lifesaving' stem-cell therapy helps increase success of bone marrow transplants; firm hopes to launch treatment in US in second half of 2021
Recent comments